Perioperative Management of Paediatric Patients with Sickle Cell Disease

被引:0
作者
Sullivan, K. J. [1 ,2 ,3 ,4 ]
Dayan, J. [1 ,2 ]
Reichenbach, M. [5 ]
Irwin, M. [3 ,4 ]
Pitkin, A. [3 ,4 ]
Gauger, C. [2 ,6 ]
Goodwin, S. R. [1 ,2 ]
Kissoon, N. [7 ]
机构
[1] Nemours Children Clin, Dept Anesthesiol, Jacksonville, FL USA
[2] Wolfson Children Hosp, Jacksonville, FL USA
[3] Univ Florida, Dept Anesthesiol, 1600 SW Archer Rd,POB 100254, Gainesville, FL 32610 USA
[4] Univ Florida, Congenital Heart Ctr, 1600 SW Archer Rd,POB 100254, Gainesville, FL 32610 USA
[5] Univ Cent Florida, Orlando, FL 32816 USA
[6] Nemours Children Clin, Dept Hematol Oncol, Jacksonville, FL USA
[7] Univ British Columbia, Childrens Hosp British Columbia, Vancouver, BC, Canada
关键词
Paediatric patients; perioperative management; sickle cell disease; PAINFUL CRISIS; NITRIC-OXIDE; CARDIOPULMONARY BYPASS; PULMONARY-HYPERTENSION; SURGICAL-PROCEDURES; SIMPLE TRANSFUSION; CHILDREN; ANEMIA; EXCHANGE; SURGERY;
D O I
10.7727/wimj.2017.135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with sickle cell disease (SCD) are prone to acute and chronic organ injuries that may necessitate surgical interventions earlier and with more frequency than non-SCD cohorts. They are also at an increased risk for perioperative morbidity and mortality because of the inherent pathophysiological derangements associated with SCD. Perioperative outcomes are influenced by phenotype variability, end-organ injury and the variable risks of surgical procedures, as well as the availability of beneficial therapies, especially where resources may be limited. Safe and effective perioperative management relies on anticipation and avoidance of complications, which can be best achieved by collaboration among anaesthesiologists, intensivists, surgeons and haematologists. This review addresses potential perioperative complications and contemporary management to assist in the perioperative care of paediatric patients with SCD.
引用
收藏
页码:469 / 477
页数:9
相关论文
共 50 条
[1]  
Adams R J., 1998, NEW ENGL J MED, V339, P5, DOI [10.1056/NEJM199807023390102, DOI 10.1056/NEJM199807023390102]
[2]  
Adams RJ, 2005, NEW ENGL J MED, V353, P2769
[3]   Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke Findings From Get With The Guidelines-Stroke [J].
Adams, Robert J. ;
Cox, Margueritte ;
Ozark, Shelly D. ;
Kanter, Julie ;
Schulte, Phillip J. ;
Xian, Ying ;
Fonarow, Gregg C. ;
Smith, Eric E. ;
Schwamm, Lee H. .
STROKE, 2017, 48 (03) :686-691
[4]  
Al-Jaouni S, 2006, BAHRAIN MED B, V28, P1
[5]   Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin [J].
Assis, A ;
Conran, N ;
Canalli, AA ;
Lorand-Metze, I ;
Saad, STO ;
Costa, FF .
ACTA HAEMATOLOGICA, 2005, 113 (02) :130-136
[6]   Transfusion therapy for sickle cell disease: a balancing act [J].
Chou, Stella T. .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, :439-446
[7]   High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors [J].
Chou, Stella T. ;
Jackson, Tannoa ;
Vege, Sunitha ;
Smith-Whitley, Kim ;
Friedman, David F. ;
Westhoff, Connie M. .
BLOOD, 2013, 122 (06) :1062-1071
[8]  
Crawford MW, 2005, CAN J ANAESTH, V52, P1058, DOI 10.1007/BF03021605
[9]   Environmental Influences on Daily Emergency Admissions in Sickle-Cell Disease Patients [J].
Dessap, Armand Mekontso ;
Contou, Damien ;
Dandine-Roulland, Claire ;
Hemery, Francois ;
Habibi, Anoosha ;
Charles-Nelson, Anais ;
Galacteros, Frederic ;
Brun-Buisson, Christian ;
Maitre, Bernard ;
Katsahian, Sandrine .
MEDICINE, 2014, 93 (29) :e280
[10]  
EATON W A, 1987, Blood, V70, P1245